AbbVie Inc.
ABBV
$211.96
-$6.08-2.79%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.65% | 8.39% | 5.60% | 3.83% | 4.31% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.65% | 8.39% | 5.60% | 3.83% | 4.31% |
| Cost of Revenue | 3.43% | -1.50% | 5.14% | -3.62% | -0.14% |
| Gross Profit | 7.96% | 13.27% | 5.79% | 7.23% | 6.24% |
| SG&A Expenses | -3.95% | 5.14% | -19.02% | 22.38% | 5.11% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -104.14% | -- | -- |
| Total Operating Expenses | 1.82% | 3.92% | -2.66% | 9.87% | 6.05% |
| Operating Income | 15.79% | 20.23% | 23.74% | -8.53% | 1.15% |
| Income Before Tax | -27.59% | -5.36% | -287.21% | 6.71% | -17.78% |
| Income Tax Expenses | -20.70% | -2.87% | -678.87% | 202.33% | 32.59% |
| Earnings from Continuing Operations | -31.46% | -6.05% | -102.79% | -12.18% | -32.26% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 0.00% | 0.00% | 150.00% | 0.00% | 0.00% |
| Net Income | -31.53% | -6.06% | -102.68% | -12.20% | -32.31% |
| EBIT | 15.79% | 20.23% | 23.74% | -8.53% | 1.15% |
| EBITDA | 9.93% | 11.89% | 16.61% | -8.02% | -1.00% |
| EPS Basic | -31.76% | -6.05% | -103.95% | -12.32% | -32.48% |
| Normalized Basic EPS | 12.98% | 17.14% | 20.91% | -10.05% | 0.14% |
| EPS Diluted | -32.40% | -6.27% | -104.09% | -12.32% | -32.48% |
| Normalized Diluted EPS | 12.97% | 17.13% | 20.91% | -9.99% | 0.20% |
| Average Basic Shares Outstanding | 0.00% | -0.06% | -0.17% | 0.11% | 0.06% |
| Average Diluted Shares Outstanding | 0.00% | -0.06% | -0.17% | 0.06% | 0.00% |
| Dividend Per Share | 5.81% | 5.81% | 5.81% | 4.73% | 4.73% |
| Payout Ratio | 0.55% | 0.12% | -40.16% | 0.19% | 0.55% |